Julia Eschenbrenner, CEO of PoroUS

Age-related illnesses have a dramatic impact on quality of life as global populations continue to grow older. Among these conditions, bone health has a significant impact as deterioration can lead to disability and lengthy rehabilitation in the elderly, particularly those who suffer from osteoporosis.

Currently, osteoporosis and similar conditions can only be diagnosed using the DEXA bone mineral density scan, which uses radiation. Now, ultrasound technology may open up a new method that improves upon the gold-standard diagnosis.

In this episode of BioInnovator Spotlight, we talk to Julia Eschenbrenner, CEO of PoroUS, which is using ultrasound technology to observe the microstructure of a patient's bone surface to determine its health. She also shares her journey into life science and why she decided to take on the CEO role.